000 01477 a2200445 4500
005 20250517141431.0
264 0 _c20181029
008 201810s 0 0 eng d
022 _a1989-2284
024 7 _a10.1016/j.nefro.2016.11.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLópez-Oliva, María O
245 0 0 _aSwitch to belatacept in kidney graft recipients.
_h[electronic resource]
260 _bNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
_c
300 _a550-552 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAbatacept
_xtherapeutic use
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aDrug Substitution
650 0 4 _aEverolimus
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aKidney Transplantation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aTacrolimus
_xtherapeutic use
700 1 _aÁlvarez, Laura
700 1 _aTestillano, Mª Luisa
700 1 _aPérez, Tamara
700 1 _aNieto, María Fernández
700 1 _aSantana, Mª José
700 1 _aGonzález, Elena
700 1 _aHerrero, Alicia
700 1 _aSelgas, Rafael
700 1 _aJiménez, Carlos
773 0 _tNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
_gvol. 37
_gno. 5
_gp. 550-552
856 4 0 _uhttps://doi.org/10.1016/j.nefro.2016.11.001
_zAvailable from publisher's website
999 _c26910149
_d26910149